The Desmond Tutu
HIV Foundation

Pairing rigorous research with community-driven development, the DTHF is making a substantial contribution to service delivery and public health policy relating to HIV, tuberculosis and related infections in South Africa.

About Us Our People

HIV weekly news update in partnership with MedicalBrief

  • MEDICALBRIEF Issue No 207 – HIV News 14 May 2018

    Online predictive computer models can optimise HIV therapy in patients failing treatment

    Predictive computer models designed to optimise HIV therapy in countries with limited healthcare resources have been published online. The models accurately predict how an individual on failing therapy will respond to any new combination of HIV drugs.
  • MEDICALBRIEF Issue No 207 – HIV News 14 May 2018

    Hepatitis B or raised liver enzymes predict liver toxicity with INH prophylaxis

    The risk of liver toxicity in people with HIV taking antiretroviral therapy and isoniazid preventive therapy for tuberculosis is strongly associated with either hepatitis B co-infection or pre-existing liver enzyme elevations, according to international research.
  • MEDICALBRIEF Issue No 207 – HIV News 14 May 2018

    Understanding how partnerships help with ART adherence

    A recent study conducted in Botswana suggests that individuals whose partners provided more holistic, non-medical support, were more likely to be virally suppressed.
  • MEDICALBRIEF Issue No 207 – HIV News 14 May 2018

    Pro-140 on track to be part of combination MDR/HIV treatment

    Positive results support the continued development of PRO 140 – CytoDyn’s investigational humanised monoclonal antibody for the treatment of patients with HIV who are failing their current ART regimens.
  • MEDICALBRIEF Issue No 206 – HIV News 31 May 2018

    WHO, EMA and FDA warn on dolutegravir and birth defects

    Within a week, the 'revolutionary' HIV drug dolutegravir has gone from being highly regarded to being the subject of international warnings. Health-e News reports that recent data from a Botswana study linking it to birth defects has seen the World Health Organisation,European Medicines Agency and the US Food and Drug Administration, unanimously issuing warnings statements.
View All

Our Research


Women of Worth graduation

Graduation Day The Zimele project graduated their first group of participants from the Women of Worth programme in a ceremony …
Read More

Introducing the 2018-2019 Tutu PhD Candidate: Tracey Naledi

The Desmond Tutu HIV Centre and the Desmond and Leah Tutu Legacy Foundation are delighted to announce the 2018-19 Tutu …
Read More

17 May 2018: Conversations surrounding International Day Against Homophobia, Transphobia and Biphobia

On the 17th of May 2018, countries around the world will gather in celebration of the annual International Day Against Homophobia, Transphobia and Biphobia (IDAHOTB). This follows …
Read More

Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines.

Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) based at the University of Cape Town and the Desmond Tutu …
Read More

Our Projects

Desmond Tutu HIV Centre: Postgraduate Diploma in TB-HIV Medicine

Overview The Desmond Tutu HIV Centre and the University of Cape Town are proud to present the first online postgraduate …
Read More

The Tutu Tester

HIV and TB are managed successfully in many countries around the world. Yet, millions of people are still missing care. …
Read More

Adult HIV Educational Programme

Order a Manual Free Online Manual The aim of the HIV education programme is to improve the care of men …
Read More


Youth Centre
Youth Centre

The DTHF Youth Centre

The DTHF Youth Centre complex in Masiphumelele was built in response to requests from the community for a safe, recreational space for young people. DTHF surveys record a high prevalence of HIV infection among youth in the community.

Visit the Youth Centre